SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-20-002947
Filing Date
2020-11-13
Accepted
2020-11-13 17:20:11
Documents
2
Period of Report
2020-11-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form312566001_11132020.html 3  
1 OWNERSHIP DOCUMENT form312566001_11132020.xml 3 6587
2 ex24form312566001_11132020.htm EX-24 7207
  Complete submission text file 0000921895-20-002947.txt   15380
Mailing Address MAKY ZANGANEH & ASSOCIATES 2087 SHARON ROAD MENLO PARK CA 94025
Business Address
Zanganeh Maky (Reporting) CIK: 0001507650 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36866 | Film No.: 201312618

Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations